title: Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
authors: Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, and the Northwest Lipid Laboratory, University of Washington, Seattle, Washington, USA.
authors: John D
authors: JD
authors: Brunzell
authors: Michael
authors: M
authors: Davidson
authors: Curt D
authors: CD
authors: Furberg
authors: Ronald B
authors: RB
authors: Goldberg
authors: Barbara V
authors: BV
authors: Howard
authors: James H
authors: JH
authors: Stein
authors: Joseph L
authors: JL
authors: Witztum
mesh_terms: D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003925:Diabetic Angiopathies / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D008074:Lipoproteins / Q000097:blood* / Q000378:metabolism; D012307:Risk Factors; D012955:Societies, Medical; D014481:United States; D014837:Voluntary Health Agencies
chemical_list: D008078:Cholesterol, LDL; D008074:Lipoproteins